194 related articles for article (PubMed ID: 19147787)
1. Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas.
Frank MJ; Dawson DW; Bensinger SJ; Hong JS; Knosp WM; Xu L; Balatoni CE; Allen EL; Shen RR; Bar-Sagi D; Martin GR; Teitell MA
Blood; 2009 Mar; 113(11):2478-87. PubMed ID: 19147787
[TBL] [Abstract][Full Text] [Related]
2. Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL.
Shukla A; Rai K; Shukla V; Chaturvedi NK; Bociek RG; Pirruccello SJ; Band H; Lu R; Joshi SS
Blood; 2016 May; 127(19):2310-21. PubMed ID: 26809508
[TBL] [Abstract][Full Text] [Related]
3. Dysregulated TCL1 requires the germinal center and genome instability for mature B-cell transformation.
Shen RR; Ferguson DO; Renard M; Hoyer KK; Kim U; Hao X; Alt FW; Roeder RG; Morse HC; Teitell MA
Blood; 2006 Sep; 108(6):1991-8. PubMed ID: 16728701
[TBL] [Abstract][Full Text] [Related]
4. Synergistic role of Sprouty2 inactivation and c-Met up-regulation in mouse and human hepatocarcinogenesis.
Lee SA; Ladu S; Evert M; Dombrowski F; De Murtas V; Chen X; Calvisi DF
Hepatology; 2010 Aug; 52(2):506-17. PubMed ID: 20683950
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic silencing of Stk39 in B-cell lymphoma inhibits apoptosis from genotoxic stress.
Balatoni CE; Dawson DW; Suh J; Sherman MH; Sanders G; Hong JS; Frank MJ; Malone CS; Said JW; Teitell MA
Am J Pathol; 2009 Oct; 175(4):1653-61. PubMed ID: 19717643
[TBL] [Abstract][Full Text] [Related]
6. Global DNA methylation profiling reveals silencing of a secreted form of Epha7 in mouse and human germinal center B-cell lymphomas.
Dawson DW; Hong JS; Shen RR; French SW; Troke JJ; Wu YZ; Chen SS; Gui D; Regelson M; Marahrens Y; Morse HC; Said J; Plass C; Teitell MA
Oncogene; 2007 Jun; 26(29):4243-52. PubMed ID: 17260020
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of Spry2 accelerates AKT-driven hepatocarcinogenesis via activation of MAPK and PKM2 pathways.
Wang C; Delogu S; Ho C; Lee SA; Gui B; Jiang L; Ladu S; Cigliano A; Dombrowski F; Evert M; Calvisi DF; Chen X
J Hepatol; 2012 Sep; 57(3):577-83. PubMed ID: 22617155
[TBL] [Abstract][Full Text] [Related]
8. Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma.
Fong CW; Chua MS; McKie AB; Ling SH; Mason V; Li R; Yusoff P; Lo TL; Leung HY; So SK; Guy GR
Cancer Res; 2006 Feb; 66(4):2048-58. PubMed ID: 16489004
[TBL] [Abstract][Full Text] [Related]
9. Sprouty2 positively regulates T cell function and airway inflammation through regulation of CSK and LCK kinases.
Sripada A; Sirohi K; Michalec L; Guo L; McKay JT; Yadav S; Verma M; Good J; Rollins D; Gorska MM; Alam R
PLoS Biol; 2021 Mar; 19(3):e3001063. PubMed ID: 33684096
[TBL] [Abstract][Full Text] [Related]
10. Sprouty2 enhances the tumorigenic potential of glioblastoma cells.
Park JW; Wollmann G; Urbiola C; Fogli B; Florio T; Geley S; Klimaschewski L
Neuro Oncol; 2018 Jul; 20(8):1044-1054. PubMed ID: 29635363
[TBL] [Abstract][Full Text] [Related]
11. Spatial signal repression as an additional role of Sprouty2 protein variants.
Dittmer J; Stütz A; Vanas V; Salhi J; Reisecker JM; Kral RM; Sutterlüty-Fall H
Cell Signal; 2019 Oct; 62():109332. PubMed ID: 31154002
[TBL] [Abstract][Full Text] [Related]
12. TCL1 in B-cell tumors retains its normal b-cell pattern of regulation and is a marker of differentiation stage.
Herling M; Patel KA; Hsi ED; Chang KC; Rassidakis GZ; Ford R; Jones D
Am J Surg Pathol; 2007 Jul; 31(7):1123-9. PubMed ID: 17592280
[TBL] [Abstract][Full Text] [Related]
13. T Cell Leukemia/Lymphoma 1A is essential for mouse epidermal keratinocytes proliferation promoted by insulin-like growth factor 1.
Bresin A; Ragone G; Cristofoletti C; Arcelli D; Bassi C; Caprini E; Fiorenza MT; Helmer Citterich M; Russo G; Narducci MG
PLoS One; 2018; 13(10):e0204775. PubMed ID: 30286151
[TBL] [Abstract][Full Text] [Related]
14. G Protein-regulated inducer of neurite outgrowth (GRIN) modulates Sprouty protein repression of mitogen-activated protein kinase (MAPK) activation by growth factor stimulation.
Hwangpo TA; Jordan JD; Premsrirut PK; Jayamaran G; Licht JD; Iyengar R; Neves SR
J Biol Chem; 2012 Apr; 287(17):13674-85. PubMed ID: 22383529
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia inducible factors regulate the transcription of the sprouty2 gene and expression of the sprouty2 protein.
Gao X; Hicks KC; Neumann P; Patel TB
PLoS One; 2017; 12(2):e0171616. PubMed ID: 28196140
[TBL] [Abstract][Full Text] [Related]
16. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2.
He Y; Ge Y; Jiang M; Zhou J; Luo D; Fan H; Shi L; Lin L; Yang L
Cell Physiol Biochem; 2018; 47(4):1465-1481. PubMed ID: 29949784
[TBL] [Abstract][Full Text] [Related]
17. Sprouty2 and Spred1-2 proteins inhibit the activation of the ERK pathway elicited by cyclopentenone prostanoids.
García-Domínguez CA; Martínez N; Gragera T; Pérez-Rodríguez A; Retana D; León G; Sánchez A; Oliva JL; Pérez-Sala D; Rojas JM
PLoS One; 2011 Feb; 6(2):e16787. PubMed ID: 21364986
[TBL] [Abstract][Full Text] [Related]
18. Dysregulated TCL1 promotes multiple classes of mature B cell lymphoma.
Hoyer KK; French SW; Turner DE; Nguyen MT; Renard M; Malone CS; Knoetig S; Qi CF; Su TT; Cheroutre H; Wall R; Rawlings DJ; Morse HC; Teitell MA
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14392-7. PubMed ID: 12381789
[TBL] [Abstract][Full Text] [Related]
19. Tesk1 interacts with Spry2 to abrogate its inhibition of ERK phosphorylation downstream of receptor tyrosine kinase signaling.
Chandramouli S; Yu CY; Yusoff P; Lao DH; Leong HF; Mizuno K; Guy GR
J Biol Chem; 2008 Jan; 283(3):1679-1691. PubMed ID: 17974561
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms.
Sutterlüty H; Mayer CE; Setinek U; Attems J; Ovtcharov S; Mikula M; Mikulits W; Micksche M; Berger W
Mol Cancer Res; 2007 May; 5(5):509-20. PubMed ID: 17510316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
